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ABSTRACT 
The Clinical Research Center for New Drugs and Therapeutics has been established in 
Tottori University Hospital in December 2000 to promote the speedy accomplishment of 
high quality clinical research. We investigated the perceptions and attitudes of 200 out-
patients toward clinical research on new drugs and provided information on some aspects 
of drugs and clinical research on new drugs. We also performed a similar survey of 415 
nurses in the Tottori University Hospital. One hundred and forty-three outpatients 
(response rate of 71.5%) and 291 nurses (70.1%) cmpleted this questionnaire. A high 
rate of understanding general information regarding drugs was observed in both outpatients 
(89.5%) and nurses (96.8%). However， the rate of understanding general information 
regarding clinical research on new drugs was relatively low among outpatients (54.0%) 
compared with that among nurses (85.0%). Many outpatients did not know about the in-
stitutional review board for clinical research. Many outpatients (65.0%) expressed unwil-
lingness to participate in clinical research. These patients had less understanding about the 
systems of clinical research， ethical aspects (protection of patients health and rights， instituω 
tional review board)， and financial support for attending the hospital for research. The 
majority of outpatients (88.9%) indicated that it was necessary to become more informed 
外来患者と看護師の治験認識 269 
about clinica1 research on new drugs. They (93.7%) considered the activities of the clini-
ca1 research center on new drugs and therapeutics favorab1e， and expected the institution 
to act as an information supp1ier. These resu1ts show the rationa1e for the promotion of in-
formationa1 activities of the clinica1 research center for new drugs and therapeutics at Tot-
tori University Hospital. (Accepted on October 1， 2004) 




















































































































1) 治験に協力することに抵抗はありますか。 口はい 口いいえ




4) 治験についてもっとよく知りたいですか。 口はい 巴いいえ
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図4.
経て認可されることなどの概略を認識している患































































1 治験について聞いた事がある 54.5% 
2 治験についてもっと知りたい 74.1% 
3 有用な新薬が治験を経て認可される概略を認識 80~90% 
4 治験審査委員会の独立性を認識 42.3% 
5 治験に伴う検査や薬代の負担がないことや !低い
負担軽減費の制度等を知っている 41. 3% 




























































































































































l 治験に協力することに抵抗あり 65.0% 





人権保護，治験審査委員会の役割や運営 同 38.9% 
負担軽減費の制度 問 44.4%
































































































































名， 68.6%)， IC取得に同席する (213名， 63.0 
%)，患者の状態を底師に倍達する (113名， 33.4 
%)，医師と患者の関係調整をする (63名， 18.6 
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